Jul 11, 2023
5:2
For every 2 shares held, investors received 5. The price per share adjusted from $167200.00 to $66880.00.
The split itself did not change the total investment value.
Central Pharmaceutical JSC No. 3 (HNX:DP3) operates in the Pharmaceuticals: other industry.
Central Pharmaceutical JSC No. 3 company overviewCentral Pharmaceutical JSC No. 3's most recent stock split was on July 11, 2023. It was a 5-for-2 forward split, so shareholders received 5 shares for every 2 they held.
Central Pharmaceutical JSC No. 3 (HNX:DP3) has split its stock 3 times: a 25-for-22 split on December 31, 2015, a 1053-for-980 split on February 12, 2019, and a 5-for-2 split on July 11, 2023.
Central Pharmaceutical JSC No. 3 has split its stock 3 times. This history records 3 forward splits between December 31, 2015 and July 11, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Central Pharmaceutical JSC No. 3's 5-for-2 split on July 11, 2023, every 2 shares became 5 shares.
Central Pharmaceutical JSC No. 3 has not announced a new split in our records. Its most recent split was on July 11, 2023, 3 years ago. Companies announce splits in advance, and any new HNX:DP3 split will appear on this page.
Already premium?